Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6LRM

Crystal structure of PDE4D catalytic domain in complex with arctigenin

Summary for 6LRM
Entry DOI10.2210/pdb6lrm/pdb
DescriptorcAMP-specific 3',5'-cyclic phosphodiesterase 4D, ZINC ION, MAGNESIUM ION, ... (6 entities in total)
Functional Keywordspde4d, inhibitor, complex structure, hydrolase
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight82730.73
Authors
Zhang, X.L.,Li, M.J.,Xu, Y.C. (deposition date: 2020-01-16, release date: 2021-04-14, Last modification date: 2023-11-29)
Primary citationLi, H.,Zhang, X.,Xiang, C.,Feng, C.,Fan, C.,Liu, M.,Lu, H.,Su, H.,Zhou, Y.,Qi, Q.,Xu, Y.,Tang, W.
Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation.
J Adv Res, 33:241-251, 2021
Cited by
PubMed Abstract: Arctigenin, derived from Arctium lappa L., has multiple pharmacological activities, including immunoregulatory, anti-diabetic, anti-tumor, and neuroprotective effects. Nevertheless, the potential therapeutic target of arctigenin in modulating inflammation remains undefined.
PubMed: 34603793
DOI: 10.1016/j.jare.2021.02.006
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.45 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon